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Abstract
Objective:  To  review  the  available  literature  on  the  association  between  acute  viral  respiratory
tract infection  and  the  onset  of  asthma  exacerbations,  identifying  the  most  prevalent  viruses,
detection  methods,  as  well  as  preventive  and  therapeutic  aspects.
Sources: A  search  was  conducted  in  PubMed,  Lilacs,  and  SciELO  databases,  between  the  years
2002  and  2013,  using  the  following  descriptors:  asthma  exacerbation,  virus,  child,  and  acute
respiratory  infection.
Summary of  the  ﬁndings:  A  total  of  42  original  articles  addressing  the  identiﬁcation  of  respi-
ratory viruses  during  episodes  of  asthma  exacerbation  were  selected,  mostly  cross-sectional
studies.  There  was  a  wide  variation  in  the  methodology  of  the  assessed  studies,  particularly  in
relation  to  the  children’s  age  and  methods  of  collection  and  viral  detection.  The  results  indicate
that,  in  up  to  92.2%  of  exacerbations,  a  viral  agent  was  potentially  the  main  triggering  factor,
and  human  rhinovirus  was  the  most  frequently  identiﬁed  factor.  The  pattern  of  viral  circulation
may  have  been  responsible  for  the  seasonality  of  exacerbations.  The  association  between  viral
infections  and  allergic  inﬂammation  appears  to  be  crucial  for  the  clinical  and  functional  uncon-
trolled  asthma,  but  few  studies  have  evaluated  other  triggering  factors  in  association  with  viral
infection.
Conclusions:  Respiratory  viruses  are  present  in  the  majority  of  asthmatic  children  during
episodes of  exacerbation.  The  involved  physiopathological  mechanisms  are  yet  to  be  fully
established,  and  the  synergism  between  allergic  inﬂammation  and  viral  infection  appears  to
determine  uncontrolled  disease.  The  role  of  other  triggering  and  protective  agents  is  yet  to  be
clearly  determined.
 Please cite this article as: Costa LD, Costa PS, Camargos PA. Exacerbation of asthma and airway infection: is the virus the villain? J
ediatr (Rio J). 2014;90:542--55.
 Study conducted at the Department of Pediatrics, Universidade Federal de Goiás (UFG), Goiânia, GO, Brazil.
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respiratório
Exacerbac¸ão  da  asma  e  infecc¸ão  das  vias  aéreas:  o  vírus  é  o  vilão?
Resumo
Objetivo:  Rever  a  literatura  disponível  sobre  a  relac¸ão  entre  infecc¸ão  viral  aguda  do  trato  respi-
ratório e  o  desencadeamento  de  exacerbac¸ões  da  asma,  identiﬁcando  os  vírus  mais  prevalentes,
os  métodos  de  detecc¸ão,  bem  como  os  aspectos  preventivos  e  terapêuticos.
Fonte dos  dados:  Foi  realizada  uma  busca  nas  bases  de  dados  PubMed,  SciELO  e  Lilacs  utilizando
os descritores:  asma,  exacerbac¸ão,  vírus,  crianc¸a e  infecc¸ão  respiratória  aguda,  entre  os  anos
de  2002  e  2013.
Síntese dos  dados:  Foram  selecionados  42  artigos  originais  que  tratavam  da  identiﬁcac¸ão  de
vírus respiratórios  durante  episódios  de  exacerbac¸ão  da  asma,  em  sua  maioria  estudos  transver-
sais.  Houve  ampla  variac¸ão  na  metodologia  dos  trabalhos  avaliados,  principalmente  em  relac¸ão
à idade  das  crianc¸as  e  métodos  de  coleta  e  detecc¸ão  viral.  Os  resultados  apontam  que,  em  até
92,2%  das  exacerbac¸ões,  um  agente  viral  foi  potencialmente  o  principal  fator  desencadeante,
sendo o  rinovírus  humano  o  mais  identiﬁcado.  O  padrão  de  circulac¸ão  viral  pode  ter  sido
responsável  pela  sazonalidade  das  exacerbac¸ões.  A  associac¸ão  entre  infecc¸ão  viral  e  inﬂamac¸ão
alérgica parece  ser  determinante  para  levar  ao  descontrole  clínico-funcional  da  asma,  porém
poucos  estudos  avaliaram  outros  fatores  desencadeantes  em  associac¸ão  com  a  infecc¸ão  viral.
Conclusões:  Os  vírus  respiratórios  estão  presentes  na  maioria  das  crianc¸as  asmáticas  durante
os episódios  de  exacerbac¸ão.  Os  mecanismos  ﬁsiopatológicos  envolvidos  ainda  não  estão
totalmente  estabelecidos  e  o  sinergismo  entre  a  inﬂamac¸ão  alérgica  e  infecc¸ão  viral  parece
determinar o  descontrole  da  doenc¸a.  O  papel  dos  outros  agentes  desencadeantes  e  protetores
não estão  claramente  determinados.
© 2014  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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infection in  asthmatic  children  during  exacerbation  were
selected. Some  articles  of  historical  importance  or  review
articles that  included  the  three  descriptors  were  added  to
Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
Asthma  is  a  chronic,  genetically-determined  disease,  whose
prevalence in  the  pediatric  population  ranges  between
19.0% and  24.3%  among  brazilian  adolescents  and  schoolchil-
dren, respectively.1 From  the  physiopathological  viewpoint,
it is  characterized  by  chronic  inﬂammation  with  the
involvement of  several  cell  types,  associated  with  airway
hyperresponsiveness, with  episodes  of  reversible  airﬂow
limitation. It  is  clinically  manifested  by  recurrent  exacerba-
tions, also  called  ‘‘asthma  attacks’’  or,  more  appropriately,
acute asthma,  characterized  by  progressive  worsening  of
dyspnea, coughing,  wheezing,  chest  tightness,  or  a  combi-
nation of  these.2
The  loss  of  clinical  and  functional  asthma  control  usually
occurs gradually,  but  it  can  occur  abruptly  in  a  subgroup  of
patients.2 It  is  one  of  the  main  causes  of  emergency  consul-
tations, having  been  responsible,  in  2007,  for  195  deaths
in children  younger  than  19  years  in  Brazil.3 Public  policies
have been  developed  to  promote  both  scientiﬁc  knowledge
about the  disease  and  its  management,  as  well  as  to  organize
assistance programs  in  public  health,  which  include,  among
others, the  dispensing  of  medications.  However,  exacerba-
tions continue  to  represent  a  signiﬁcant  number  in  statistics,
with great  impact  on  public  and  private  healthcare  systems.2
The  multifactorial  origin  of  the  clinical-functional  lack
of disease  control  is  well  known;  since  the  early  1970s,
respiratory viruses  have  been  associated  with  the  trigger-
ing of  asthma  exacerbations  in  adults  and  children.3 In
the 1990s,  the  development  of  more  sensitive  and  speciﬁc
molecular techniques  allowed  for  the  increase  in  respiratory
virus detection  and  therefore,  ways  to  better  explain  this
g
e
Ussociation.  Studies  using  reverse  transcriptase  polymerase
hain reaction  (RT-PCR)  as  the  detection  technique,  isolated
r combined  with  traditional  methods,  observed  positivity
or respiratory  viruses  in  up  to  92.2%  of  episodes  of  acute
sthma exacerbation  in  children.4
Considering  the  possibility  of  a  causal  relationship
etween respiratory  virus  infection  and  the  triggering  of
sthma attacks  in  children,  the  implications  of  this  asso-
iation, as  well  as  the  possibility  of  speciﬁc  prophylaxis  and
herapy for  these  agents,  special  attention  to  this  subject  is
ustiﬁed. Therefore,  this  literature  review  aimed  to  analyze
rticles, published  between  2002  and  2013,  assessing  the
ssociation between  asthma  exacerbation  and  acute  viral
irway infection.
ethods
 search  was  conducted  in  the  PubMed,  Lilacs  and  SciELO
atabases, using  the  descriptors:  ‘‘Asthma  Exacerbation’’,
‘Viral Infection’’,  and  ‘‘Child’’,  resulting  in  a  total  of
83 references  for  that  period.  After  selecting  the  articles
ublished in  Portuguese,  English,  Spanish,  or  French,  195
rticles  remained.  After  reading  the  titles  and  abstracts,
2 original  articles  that  assessed  respiratory  tract  viralenerate the  bibliography  of  this  review.  The  list  of  refer-
nces was  inserted  into  Endnote  X6  (Thompson  Corp.,  CA,
SA), a  bibliographic  citation  management  software.
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espiratory  viruses  and  immune  response
he  most  frequently  identiﬁed  respiratory  viruses  in  asso-
iation with  asthma  exacerbation  were  human  rhinovirus
HRV), respiratory  syncytial  virus  (RSV),  human  adenovirus
hAdV), inﬂuenza  (Flu),  Parainﬂuenza  (PFlu),  human  metap-
eumovirus (hMPV),  and  human  coronavirus  (hCoV).  Of  the
isted viruses,  most  have  RNA  as  the  nucleic  acid;  their
iological characteristics  and  taxonomy5 are  described  in
able 1.
The main  transmission  methods  for  these  viruses  are
hrough contaminated  fomites,  droplets,  aerosols,  or  direct
ontamination. By  infecting  the  nasal  epithelium  cells,  these
gents trigger  an  immune  response,  which  involves  mainly
he dendritic  cells  and  natural  killer  (NK)  cells,  inducing
he release  of  a  number  of  pro-inﬂammatory  cytokines  and
hemokines by  the  infected  epithelial  cells,  such  as  inter-
eron (IFN-1)  and  tumor  necrosis  factor  alpha  (TNF),  among
thers (Fig.  1).
In asthma  patients,  the  viral  infection  causes  an  imbal-
nce in  the  immune  homeostasis  of  the  respiratory  system.
everal mechanisms  related  to  viral  infection  and  aller-
ic inﬂammation,  as  well  as  their  role  in  triggering  acute
sthma, have  been  proposed;  among  them,  the  deﬁcient
unction of  the  epithelial  barrier  caused  by  the  virus,  which
as been  implicated  as  a  predisposing  factor  by  some.6 How-
ver, both  asthma  and  atopy  are  associated  with  epithelial
amage, which  may  contribute  to  increased  susceptibility
o infections,  including  viral  diseases  and  sensitization  by
eroallergens.7 Another  evaluated  factor  was  mucus  pro-
uction as  an  airway  defense  mechanism;  in  mice  studies,  it
as demonstrated  that  allergic  inﬂammation  and  viral  infec-
ion act  synergistically  increasing  mucus  production,  which
an lead  to  airway  impaction  and  obstruction  in  asthma
atients.8
Virus-induced  alterations  in  interferon  production  have
lso been  observed.  For  instance,  in  vivo  and  in  vitro
tudies in  epithelial  cells  from  healthy  adults  and  asthma
atients infected  with  HRV  demonstrated  a  decreased  pro-
uction of  type  I  interferon  (  and  )  in  the  latter,  making
hem more  susceptible  to  infection  associated  with  viral
xacerbation.6,9 Similar  results  were  obtained  in  studies  per-
ormed with  children,  where  the  production  of  interferon
nd Th2  cytokines  by  bronchial  epithelial  cells  was  assessed
fter HRV-16  infection.
Lower interferon  production  and  higher  concentrations  of
iral RNA  have  been  demonstrated  in  children  with  asthma,
egardless of  their  atopic  status,  and  in  atopic  children  with-
ut asthma,  suggesting  that  an  impaired  immune  response
o viral  infection  occurs  not  only  in  asthma  patients,
ut in  children  with  other  disorders  associated  with  Th2
ymphocytes.10 However,  other  studies  failed  to  demon-
trate the  same  reduction  in  interferon  production;  others
ven found  an  increase  in  its  production  in  exacerbated
sthma.11,12
The  bronchial  epithelium  produces  some  cytokines,
ncluding interleukin  25  and  33,  as  well  as  thymic  stro-
al lymphopoietin,  which  promotes  the  differentiation  of
nnate lymphoid  cells  into  Th2.  The  latter  can  be  induced
y viral  infection,  and  its  production  can  be  increased  by
a
e
i
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nterleukin-4  (IL-4),  suggesting  that  the  interaction  between
iruses and  allergic  airway  inﬂammation  may  enhance  the
nﬂammatory Th2  response  and  potentially  reduce  the
ntiviral response.11,13
ollection  and  viral  detection  methods
iral  detection  is  highly  dependent  on  the  quality  of  the
ollected sample,  on  the  time  of  symptom  onset  to  the  time
f collection  (ideally  within  72  hours),  and  on  transportation
nd storage  of  the  sample  before  testing.  The  analysis  for
espiratory viruses  should  be  performed  in  material  from  the
irways. Upper  airway  secretion  is  used  in  most  cases,  and
everal methods  are  employed  for  this  collection,  such  as
asopharyngeal aspirate  (NPA),  nasopharyngeal  swab  (NPS),
asopharyngeal  lavage,  and  the  combined  nasal-oral  swab;
he ﬁrst  technique  is  considered  the  gold  standard.14
Recently,  new  ﬂocked  swabs  (Copan,  Brescia,  Italy)  were
eveloped, and  presented  better  performance  during  data
ollection. Recent  studies  using  this  type  of  swab  presented
 sensitivity  comparable  to  that  of  NPA  when  the  detection
s performed  by  PCR,  suggesting  that  this  swab  can  be  used
n epidemiological  research  and  surveillance  studies,  due  to
ts greater  technical  simplicity.15,16
There  are  few  data  to  support  the  use  of  combined  oral-
asal swabs  for  virus  detection,  and  its  sensitivity  is  lower
han that  of  the  nasopharyngeal  swab  or  aspirate,  which  can
e  explained  by  the  lower  viral  load  in  the  oropharynx  than
n the  nasopharynx.  The  collection  can  also  be  performed
n material  from  the  lower  airways,  such  as  induced  sputum
nd bronchial  lavage.17
The  methods  for  detection  of  respiratory  viruses  are  var-
ed and  include  rapid  tests  for  antigen  detection,  culture,
irect and  indirect  immunoﬂuorescence,  and  nucleic  acid
mpliﬁcation reactions,  such  as  RT-PCR,  which  can  detect
 single  agent  (monoplex)  or  perform  multiple  detections
multiplex). The  sensitivity  of  the  latter  is  higher,  and  it  was
sed in  most  recent  studies.18,19 immunoﬂuorescence  reac-
ions have  lower  cost,  are  faster  to  perform,  and  are  also
ble to  detect  multiple  viruses.  A  panel  of  seven  viruses  (IFlu
 and  B,  PFlu  1  to  3,  hAdV,  and  RSV)  is  generally  used.  Some
iruses, such  as  HRV  and  Bocavirus,  can  only  be  detected
hrough nucleic  acid  ampliﬁcation  reactions.17
irus  and  exacerbation
everal  authors  have  performed  studies  aiming  to  detect
iruses in  respiratory  secretions  of  exacerbated  asthma
atients, showing  a  prevalence  of  viral  identiﬁcation  that
aries with  several  factors,  such  as  patient  age,  time  of
he year,  method  of  sample  collection,  and  method  of
iral detection.  Table  2  presents  the  original  articles  that
emonstrate results  of  viral  testing  in  children  with  exacer-
ated asthma.  Most  studies  found  prevalence  rates  between
6.0%20 and  92.2%;5 in  these  cases,  the  most  frequently  iden-
iﬁed virus  was  HRV.
An  investigation  of  respiratory  viruses  in  209  children
ged between  three  and  16  years  hospitalized  for  asthma
xacerbation was  performed  over  a  period  of  12  months
n Buenos  Aires,  Argentina.  Due  to  the  possibility  of  other
iagnoses for  wheezing  episodes  in  infants,  the  deﬁnition
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Table  1  Biological  characteristics  and  taxonomy  of  the  major  respiratory  viruses.
Inﬂuenza  Parainﬂuenza Syncytial  Adenovirus  Rhinovirus  Coronavirus  Metapneumovirus  Bocavirus
Family  Orthomyxoviridae  Paramyxoviridae Paramyxoviridae Adenoviridae  Picornaviridae Coronaviridae  Paramyxoviridae Parvoviridae
Core of  nucleic
acid
RNA RNA  RNA  DNA  RNA  RNA  RNA  DNA
Symmetry  of  the
capsid
Helical Helical  Helical  Icosahedral  Icosahedral  Pleomorphic  Pleomorphic  Icosahedral
Viral  envelope Enveloped  Enveloped  Enveloped  Naked  Naked  Enveloped  Enveloped  Naked
Sensitivity  to
ether
Sensitive Sensitive  Sensitive  Resistant  Resistant  Sensitive  Sensitive  Sensitive
Type  of  nucleic
acid
Single strand
negative
Single  negative  Single  negative  Double  Single
positive
Single positive  Single  negative  Single  negative
Nucleic  acid  size
(kb/kbp)
10 to  13.6  15  15  40  7.2  27  to  31.5  13  5
Particle  size  (nm) 80 to120nm  150  to  300  150  to  300  70  to  90  28  to  30  100  to  160  150  to  600  22  to  28
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Table  2  Studies  that  investigated  viral  infection  in  exacerbated  asthmatic  children  included  in  the  literature  review.
Author,  year,
country
n  Age  Control  Collection
time
Collection  and
identiﬁcation
methods
Total
detection
More
frequently
identiﬁed
virus
Other
identiﬁed
viruses
Observations
Khetsuriani  et  al.,
2007,28
USA
65  cases
77  controls
≥ 2  years  Stable
asthma
March/2003
to  Febru-
ary/2004
Nasopharyngeal  swab
PCR (RT-PCR)  for  hRV
37%  hRV  (37%  of
total, with
60% in  cases
and 18%  in
controls)
Not
researched
Association  of
asthma
exacerbation  with
hRV infection
genogroup  C
Lopez  Perez
et al.,  2009,22
Mexico
100  cases
68 controls
2 to  17
years
Wheezers  Winter  (April
to June)
Swab
DIF
Identiﬁcation
in  75%  of
cases and
44% of
controls
FLUVA and
hRSV in
wheezers;
hAdV,  FLUVB
and PF  in
asthma
patients
hRSV,  hAdV,
FLUV
Co-detection  in
17%
Olenec et  al.,
2010,30
Korea
58  cases 6 to  8
years
No  April  and
Septem-
ber/2006,
2007 and  2008
(501
collected
samples)
NPA
multiplex  PCR;
hRV sequencing
hRV  (72  to
99%)
hRV C  in  16
cases
hRSV  A  and
B, PF  1-4,
hAdV,  hCoV,
enterovirus
and hMPV,
hBoV.
Virus  associated
with  greater
severity  and
duration;
interaction
between  allergic
sensitization  and
virus
Bizzintino et  al.,
2011,4
Australia
128  cases  2  to  16
years
No  April/2003  to
Febru-
ary/2010
NPA or  swab
DIF and  multiplex  PCR
(18  primers)  -  nine
viruses
Characterization  of
hRV (types)
92.2%  hRV  (87.5%)  hRSV,  hAdV,
FLUVA  and
B, PIV1-4,
hMPV,  hEV,
hCoV and
hBoV
hRV  C  was
detected  in  most
children with
acute asthma
(59.4%)  and
associated  to
severity
Miller et  al.,
2009,29
USA
1,052  cases  ≤  5  years  No  October/2001
to  Septem-
ber/2003
NPA  and  swab
PCR and  sequencing
for hRV
hRV  (15.9%)  Not  studied  hRV  type  C
associated  to
asthma
exacerbation
Chang et  al.,
2009,32
Austrália
201  cases  2  to  15
years
No  March/2005
to  Febru-
ary/2007
NPA
PCR  multiplex
53.8%  hRV  (41%)  hRSV,  hAdV,
FLUV,  PIV,
hMPV
Co-detection  in
ten cases
No difference  in
evolution for
deferment  viruses.
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Table  2  (Continued)
Author,  year,
country
n  Age  Control  Collection
time
Collection  and
identiﬁcation
methods
Total
detection
More
frequently
identiﬁed
virus
Other
identiﬁed
viruses
Observations
Ozcan  et  al.,
2011,25
Turkey
104  cases
31 controls
3 to  17
yeras
Stable
Asthma
patients
12  months:
Septem-
ber/2009  to
Septem-
ber/2010
Swab
Real-time  PCR
53.8%  hRV  (35.6%) FLUVA  e  B,
PIV 1-4,
hCoV,  hRSV,
hRV, hMPV
and hAdV
Camara et  al.,
2004,43
Brazil
132  cases
65 controls
0 to  12
years
Non-asthma
patients
October/1998
to  June/2000
NPA
Immunoﬂuorescence
(IIF);  culture  for  hAdV
and RT-PCR  for  hRV
and hCoV
Cases  (60.8%)
Controls
(13.3%)
RSV in  those
younger  than
2 years
hRV  and
hAdV  in
those  older
than 2  years
hRSV,  FLUV,
PIV
hAdV, hCoV
There  was  no
association
between virus
detection  and
wheezing.  Allergic
sensitization  more
associated with
exacerbation.
Kato et  al.,
2011,26
Japan
174  cases
93 controls
Median
4.7 years
Stable
Asthma
patients
Non-asthma
patients
November/2003
to
October/2003
NPA
Kit  detection  of
antigens and
RT-PCR
79%  hRV  (33.9%)  hRSV,  hAdV,
FLUV and
PIV
hEV
IL1,  5,  6,  10  and
ECP were  higher  in
exacerbation than
in controls
Rawlinson et  al.,
2003,19
Australia
179  cases
79 controls
1 month
to  16
years
Stable
Asthma
patients
Non-asthma
patients
with  URTI
Winter,  spring
and summer
of 2000  to
2002
NPA
DIF PCR  for  hRV  and
hMPV
Culture for  virus
hRV  (50%  in
total: 79%  in
cases and
17% in
controls)
hAdV,  FLUVA
e B,  hRSV,
PIV3
Co-infection  was
common
especially in
winter and  by
hRSV
Fujitsuka et  al.,
2011,23
Japan
115  Mean
20.8
months
No  November/2007
to
March/2009
Swab
PCR
86.1%  hRV  (31.3%) hRSV,  hAdV,
PIV, FLUV,
hMPV,  hRV,
hBoV, hEV
-
Dawood et  al.,
2011,27
USA
701  asthma
patients  in
2,165 cases
of inﬂuenza
2 to  17
years
No  2003  to  2009 Swab
FLUVA,  B,  H1N1
-  Only
Inﬂuenza
was
screened
Not
screened
Of  the  children
hospitalized  with
inﬂuenza in  2003,
32% and  in  2009,
44% were
asthmatics.  More
complications  with
Inﬂuenza A
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Table  2  (Continued)
Author,  year,
country
n  Age  Control  Collection
time
Collection  and
identiﬁcation
methods
Total
detection
More
frequently
identiﬁed
virus
Other
identiﬁed
viruses
Observations
Leung  et  al.,
2010,31
China
209  cases
77 controls
3 to  18
years
Stable
Asthma
patients
12  months
January/2007
to Febru-
ary/2008
NPA  or  swab
multiplex  PCR
51%  hRV  hRSV,  hAdV,
PIV, FluV,
hMPV,  hRV,
hBoV, hEV
No  agent  was
correlated  with
severity
Thumerelle et  al.,
2003,24
France
82  cases
27  controls
2 a  16
years
Stable
Asthma
patients
9  months
October/1998
to  June/1999
Swab
IIF  and  PCR
Asthma
patients
(45%)  and
controls
(3.7%)
hRV (12%)  FLUVA  and
B; PIV1-3;
hAdV;RSV;
hCoV
Mycoplasma
and
chlamydia
Serology  7.4%
Atypical 10%
Maffey  et  al.,
2010,21
Argentina
209  cases  3  months
to  16
years
No  12  months
January/2006
to Decem-
ber/2006
NPA  or  swab
IIF and  PCR
78%  RSV  and  hRV  hRSV,  hAdV
PIV1-3,
FLUVA  e  B)
hEV, hMPV,
hBoV,
mycoplasma
and
chlamydia
Co-detection  in
20%,
Seasonal
circulation: three
peaks: start  of
October (hRV);
winter (hRSV)  and
spring (hSV,  hRV
and hMPV)
Mandelcwajg
et al.,  2010,20
France
232  cases
107
controls
1.5 to  15
years
Exacerbated
asthma
patients
Non-
hospitalized
2005  to  2009
November  to
March
NPA
DIF and  PCR
47%  (hospi-
talized)
31%  (non-
hospitalized)
hBoV and
RSV
FLUVA  and
B, hAdV,
PIV-3,  hMPV
hRV  not  screened
NPA, nasopharyngeal aspirate; IIF, indirect immunoﬂuorescence; DIF, direct immunoﬂuorescence; PCR, polymerase chain reaction; RT-PCR, real-time polymerase chain reaction; hRV,
rhinovirus; hAdV, adenovirus; hRSV, respiratory syncytial virus; FLUV, Inﬂuenza; FLUVA, Inﬂuenza A; FLUVB, Inﬂuenza B; PIV1, Parainﬂuenza 1; PIV2, Parainﬂuenza 2; PIV3, Parainﬂuenza
3; hCoV, coronavirus; hMPV, metapneumovirus; hBoV, Human Bocavirus-infection; hEV, Hepatitis E vírus; ECP, eosinophil cationic protein; URTI, upper respiratory tract infection.
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Bronchial
obstruction
Goblet cell
hyperplasia
IL4 IL5 IL6 IL10 IL13 IL10 IL12 IL1
DC
DC
TH2
Neutrophils: Eosinophils: Mast cells:
Penetration of
allergens and irritants
Damage to bronchial
epithelial cells
Release of
mediators from
bronchial
epithelial cells
Recruited cells or
those already present
in the airways
Legend
Virus
Chemokines
CCL5 CCL10 CXCL8
Cytokines
IFN1 TNFα IL6
IL25 IL33 TSLP
Allergen
Mucus
lgE
Inflammation
TSLP
Vasoactive amines;
Platelet-activating factor;
Arachidonic acid derivatives;
Cytokines;
Granule proteins: ECP (eosinophil
cationic protein), EDN
(eosinophil-derived neurotoxina)
Leukotrienes and prostaglandins;
Cytokines; Chemokines.
Cytokines;
Elastase;
Myeloperoxidase;
Figure  1  Immune  process  involved  in  response  to  respiratory  viruses  and  their  association  to  allergic  inﬂammation.  Respiratory
viruses  infect  bronchial  epithelial  cells  (BECs)  through  tool-like  receptors  (TLRs).  During  replication,  they  trigger  an  inﬂammatory
process  with  induction  of  cytokine  and  chemokine  production  by  BECs,  among  them  interferon  (IFN-1),  tumor  necrosis  factor  alpha
(TNF-),  interleukins  (IL-33,  IL-25),  and  thymic  stromal  lymphopoietin  (TSLP).  The  dendritic  cells  (DCs),  components  of  the  innate
immunity,  are  directed  to  secondary  lymphoid  organs  after  capturing  viral  antigens,  where  they  stimulate  the  lymphoid  cells,  the
protagonists  of  the  speciﬁc  immune  response.  In  asthma  patients,  the  production  of  IFNs  is  reduced,  allowing  for  greater  viral
replication  and  under  stimulation  of  TSLP,  there  is  a  deviation  from  lymphoid  proﬁle  to  helper  T  lymphocyte  2  (Th2),  promoting
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causing  bronchial  obstruction  and  asthma  exacerbation.
of  asthma  was  based  on  the  criteria  of  Castro-Rodriguez
for children  younger  than  3  years,  and  on  the  Global  Ini-
tiative for  Asthma  (GINA)  criteria  for  those  older  than  3.
Immunoﬂuorescence and  PCR  were  performed  in  nasopha-
ryngeal secretions  of  the  children  and  showed  a  positive  rate
of 78.0%  for  viruses  in  general;  hRV  and  hRSV  were  the  most
frequently identiﬁed  types.  There  was  also  20.0%  of  dual
detection, with  the  involvement  of  all  analyzed  viruses.21
In  México,  the  frequency  of  the  viral  positivity  at  the
immunoﬂuorescence was  higher  in  children  with  asthma
(75.0%) than  in  a  control  group  of  wheezing  children  with-
out asthma  (44.0%).  hRV  was  not  included  in  that  study,  and
IFlu, PFlu,  and  hAdV  were  the  most  frequently  identiﬁed
virus in  the  group  of  asthma  patients.22 In  Japan,  respira-
tory viruses  were  detected  by  multiplex  PCR  in  86.1%  of
115 children  with  exacerbated  asthma,  with  a  mean  age  of
20.8 months.  The  hRSV  was  related  to  a  single  episode  of
wheezing (p  <  0.05).23 hRV  was  more  frequently  observed  in
patients with  a  history  of  asthma  (p  <  0.05).
A group  of  82  French  children  with  exacerbation  treated
at home  was  compared  to  27  stable  asthmatic  chil-
dren. Immunoﬂuorescence,  PCR,  and  serology  for  viruses
(Mycoplasma pneumoniae  and  Chlamydophila  pneumoniae)
detected a  pathogen  in  45.0%  of  samples,  with  signiﬁcantly
higher frequency  in  cases  than  in  controls  (3.7%).  Viral
detection tests  were  positive  in  38%  of  cases,  and  hRV  was
a
a
F
pbronchial  hyperreactivity  and  increased  production  of  mucus,
he  most  common  (12.0%).  In  10.0%  of  cases,  the  serologic
ests were  positive  for  both  atypical  pathogens.24
Another  series  of  104  children  with  exacerbation,  com-
ared to  31  stable  children,  was  studied  by  Turkish  authors
nd showed  positivity  of  53.8%  in  the  cases  and  22.6%  in  con-
rols, through  RT-PCR  reaction.  hRV  was  the  most  commonly
ound virus  in  35.6%  of  the  samples.25 In  Japan,  174  children
ith acute  asthma  were  compared  to  79  stable  asthmatic
hildren and  14  children  without  asthma.  Using  an  antigen
etection kit  and  RT-PCR,  respiratory  viruses  were  detected
n 79.0%  of  nasal  aspirate  samples  in  exacerbated  asthmatic
hildren, and  hRV  was  the  most  common  (33.9%).  In  parallel,
he assessment  of  inﬂammatory  markers  showed  a signiﬁ-
ant elevation  (p  <  0.01)  of  interleukins  IL-1,  5,  6,  and  10  in
erum and  in  the  nasal  aspirates  of  patients  in  exacerbation,
s well  as  an  increase  in  serum  eosinophilic  cationic  protein
ECP) levels  (p  <  0.01).26
Flu,  although  less  frequently  associated  with  these
pisodes, appears  to  be  responsible  for  increased  morbid-
ty in  patients  with  an  underlying  chronic  disease,  including
sthma. Of  2,165  children  aged  2  to  17  years  admitted  with
 diagnosis  of  infections  by  FLUV-A  and  B  between  2003
nd 2009  in  the  United  States,  44.0%  were  asthma  patients,
nd complications  were  more  signiﬁcantly  associated  with
LUV-A (p  <  0.01).  Other  viruses  were  not  assessed  in  that
opulation.27
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Another  study  compared  exacerbated  children  treated
n hospitals  (n  =  232)  with  those  treated  at  home  (n  =  107).
mmunoﬂuorescence for  Flu,  hAdV,  hRSV,  and  PIV  was  per-
ormed, as  well  as  PCR  for  Bocavirus.  A  36.0%  rate  of  viral
etection was  obtained,  but  no  difference  was  observed
egarding the  viral  proﬁle  between  inpatients  and  out-
atients. The  most  frequently  observed  viruses  were  RSV
15.0%) and  Bocavirus  (12.0%),  but  hRV  was  not  included  in
he viral  panel  of  this  study.20
A  group  of  179  Australian  children  aged  up  to  16  years  had
heir nasal  secretions  collected  in  three  periods  between
000 and  2002,  and  were  compared  with  a  control  group  of
on-asthmatic children  with  upper  respiratory  tract  infec-
ion (URTI)  in  the  same  period  and  another  group  of  28
hildren with  controlled  asthma,  assessed  during  routine
onsultations. hRV  and  hMPV  were  screened  by  RT-PCR  and  a
anel of  seven  viruses  (FLUV-  A  and  B,  PIV-  1  to  3,  hAdV,  and
RSV) was  studied  by  immunoﬂuorescence.  hRV  infection
ccounted for  50.0%  of  the  URTI  of  non-asthmatic  children,
nd co-infection  was  common,  especially  with  the  hRSV,
specially in  children  younger  than  2  years.
Children  with  symptomatic  asthma  had  the  highest  rates
f hRV  infection  (79.0%  vs.  52.0%  among  all  children).  Finally,
hildren with  controlled  asthma  had  the  lowest  rates  of  hRV
dentiﬁcation (17.0%  vs.  79.0%).19
Studies  conducted  in  200728 and  200929 aimed  to  the  iden-
iﬁcation of  hRV  in  exacerbated  asthmatic  patients  through
T-PCR, found  an  overall  frequency  of  viral  identiﬁcation
f 37.0%  and  15.9%,  respectively.  The  ﬁrst  study  used  a
roup of  comparison  consisting  of  stable  asthma  patients,  in
hich the  identiﬁcation  rate  was  lower  (18.0%)  than  in  the
ase group  (60.0%).  Both  studies  found  a  greater  association
etween exacerbations  and  the  presence  of  hRV  C.
irus  and  exacerbation  severity
nother  important  issue  in  the  complex  association  between
iruses and  asthma  is  related  to  the  intensity  of  the
ssociation of  exacerbations  with  viral  infection.  In  this
ense, several  studies4,30--34 presented  inconclusive  results,
lthough hRV  was  associated  with  increased  severity
r worse  response  to  treatment.30,33,34 The  association
etween viral  infection  and  acute  asthma  severity  was  eval-
ated in  128  children  aged  2  to  16  years.  A  positivity
ate of  92.2%  for  the  presence  of  virus  was  observed  by
irect immunoﬂuorescence  (DIF)  and  multiplex  PCR;  hRV
as detected  in  87.5%  of  cases,  and  type  C  was  observed
n half  the  cases  and  was  associated  with  greater  severity.4
Fifty-eight  asthmatic  children  aged  6  to  8  years  were
onitored for  a  period  of  ﬁve  weeks  between  April  and
eptember of  2009.  They  had  nasal  lavage  samples  collected
eekly for  multiplex  PCR  analysis,  in  addition  to  a  symptom
iary, peak  expiratory  ﬂow,  and  notes  on  rescue  medication
se. A  virus  was  detected  in  36.0%  to  50.0%  of  the  specimens;
RV was  identiﬁed  in  72.0%  to  99.0%  of  the  positive  samples,
nd was  associated  with  greater  symptom  severity.30
Nonetheless,  viral  testing  by  multiplex  PCR  for  20
athogens in  209  children  with  exacerbated  asthma  com-
ared with  77  controlled  asthma  patients,  performed  in
ong Kong  between  2007  and  2008,  showed  no  associa-
ion between  the  presence  of  the  virus  and  exacerbation
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everity.  One  virus  was  identiﬁed  in  51.0%  of  cases,  and
his detection  was,  in  general,  more  associated  with  exa-
erbations (OR  2.77;  95%  CI:  1:51  to  5:11;  p  <  0.01).  When
nalyzed individually,  no  virus  was  associated  with  exacer-
ation, although  hRV  was  the  most  frequent,  being  identiﬁed
n 26.2%  of  exacerbated  and  in  13.0%  of  controlled  asthma
atients, but  with  no  signiﬁcant  difference  (p  =  0.27).31
Nasopharyngeal  aspirate  samples  of  201  asthmatic  chil-
ren aged  between  2and  15  years  collected  during  episodes
f exacerbation  were  referred  for  viral  identiﬁcation  by  PCR.
he positivity  rate  was  53.8%;the  most  frequently  observed
ere hRV  (41.0%),  followed  by  hRSV  (9.0%).  There  was  no
ssociation with  exacerbation  severity.32
A  study  compared  the  response  to  treatment  with
ronchodilators between  exacerbated  children  with  viral
espiratory infection  symptoms  (n  =  168)  and  a group  with-
ut such  symptoms  (n  =  50).  The  mean  age  was  6.6  years,
nd exacerbation  severity  did  not  differ  between  groups.
hildren with  viral  symptoms  had  poor  response  to  bron-
hodilators, requiring  more  doses  of  beta-agonists  after  6,
2, and  24  hours.  The  viral  screening  was  conducted  in  77.0%
f cases;  hRV  was  the  most  frequently  found  virus  (61.4%).33
In  another  study,  78  exacerbated  children  were  treated
t the  hospital  and  compared  to  78  asymptomatic  adults.
ultiplex PCR  reactions  for  eight  respiratory  viruses  and
onoplex PCT  for  Enterovirus,  hRV,  and  Bocavirus  detected
he presence  of  respiratory  viruses  in  65.4%  of  cases;  hRV
as once  again  the  most  frequently  observed  virus  (52.6%).
enotyping showed  a  higher  frequency  (56.0%)  of  type  C
RV and  association  with  type  A  showed  a  worse  clinical
utcome.34
easonality  of  exacerbations
sthma exacerbations  have  seasonal  distribution,  occurring
yclically in  both  adults  and  children,  and  can  be  explained
y the  viral  circulation  pattern  or  change  in  the  level  of
ollutants and  aeroallergens.  One  example  is  what  occurs
n temperate  countries,  where  a  higher  rate  of  occurrence
s more  likely  to  be  observed  in  the  fall  and  spring  among
choolchildren.35 A  combination  of  factors  may  explain  this
henomenon, such  as  increased  circulation  of  hRV  in  late
ummer and  early  autumn,  increased  circulation  of  pollut-
nts and  aeroallergens,  and  the  return  to  school  after  the
ummer vacations.  The  inﬂuence  of  the  return  to  school
ctivities may  be  explained  by  lower  adherence  to  mainte-
ance treatment  during  the  vacation  period.  The  circulation
f other  viruses  has  been  reported  in  other  countries  in
he northern  hemisphere,  especially  hRSV  during  autumn-
inter, Flu  in  winter,  PIV-  1  and  2  in  the  fall,  and  PIV-  3  in
he spring.36,37
In  Brazil,  data  on  viral  circulation  were  collected  from
he Brazilian  system  of  epidemiological  surveillance  on  Flu
iruses and  their  counterparts  in  the  period  between  2000
nd 2010.  Samples  obtained  from  nasopharyngeal  swabs  of
atients in  different  sentinel  units  distributed  throughout
he country  were  analyzed  by  immunoﬂuorescence.  They
howed a  predominance  of  FLUV  and  hRSV,  with  circula-
ion throughout  the  year,  with  peaks  for  the  latter  between
arch and  June,  and  between  May  and  August  for  FLUV.38
o  data  were  located  concerning  the  movement  of  hRV  in
razil.
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tExacerbation  of  asthma  and  viral  infection  
Few  published  data  regarding  the  seasonality  of  exacer-
bations were  found.  To  make  a  parallel  to  virus  circulation
and the  occurrence  of  exacerbations,  the  authors  analyzed
data obtained  in  some  studies,  such  as  the  study  conducted
in the  Federal  District,  which  observed  a  higher  frequency
in the  month  of  March.39 Still  in  the  Midwest  region,  in  the
state of  Goiás,  an  increased  frequency  of  respiratory  symp-
toms, not  speciﬁed  as  asthma,  was  observed  in  winter.40
An  observation  regarding  the  distribution  of  the  occur-
rence of  asthma  in  the  state  of  Minas  Gerais  also  showed
higher concentrations  in  fall-winter,  between  May  and  July,41
indicating  a  predominance  of  respiratory  and/or  asthma
symptoms in  the  Brazilian  fall-winter  seasons.
Viral  infection  and  allergic  sensitization
In  addition  to  the  seasonal  variation  of  the  virus,  other  fac-
tors involved  in  the  genesis  of  asthma  exacerbation  may
explain this  variation,  such  as  aeroallergens  and  pollutants,
which also  vary  throughout  the  different  seasons.  It  is  likely
that the  combination  of  these  and  other  factors  result  in  the
observed seasonal  peaks  in  exacerbations.  In  the  month  of
April of  the  years  2006  and  2008,  a  study  was  conducted  in
Korea aiming  to  monitor  viral  infection  and  to  identify  sen-
sitization to  aeroallergens  in  58  children  with  acute  asthma
or diagnosis  of  a  cold,  whose  mean  age  was  6.5  years.  Chil-
dren with  allergic  sensitization  presented  the  same  number
of viral  infections,  but  with  more  symptoms  than  those  non-
sensitized.30
In  another  study,  conducted  in  Manchester,  England,  84
children hospitalized  for  exacerbation  were  compared  to
children with  stable  asthma  and  children  hospitalized  for
non-respiratory disease.  The  authors  concluded  that  the
association between  viral  infection  and  allergen  exposure
increased the  risk  of  hospital  admission  by  19.4-fold.42
In  Brazil,  Camara  et  al.43 investigated  the  role  of  viral
infections, sensitization,  and  exposure  to  aeroallergens  as
risk factors  for  wheezing  in  children  aged  up  to  12  years.  In
those younger  than  2  years,  the  frequency  of  viral  positivity
was signiﬁcantly  higher  in  cases  (60.8%)  than  in  controls
(13.3%). In  older  children,  there  was  no  signiﬁcant  differ-
ence: 69.7%  of  cases  and  43.4%  of  the  positive  controls.  They
concluded that  in  children  younger  than  2  years,  the  risk
factors associated  with  wheezing  were  viral  infection  and  a
family history  of  atopy;  among  older  children,  sensitization
to inhalant  allergens  was  the  most  important  event  for  the
onset of  crises.
Pollutants  and  aeroallergens
The  effect  of  air  pollutants  is  usually  disregarded  in  the
presence of  viruses  or  allergens.  However,  there  is  evidence
that acute  exposure  to  speciﬁc  pollutants  may  contribute  to
the symptoms  and  severity  of  exacerbations.  For  instance,
cigarette smoke  induces  a  model  of  non-eosinophilic  inﬂam-
mation with  relative  resistance  to  corticosteroids.44 Passive
smoking is  quite  common  in  homes  of  asthmatic  children,
causing a  negative  impact  on  disease  control.  In  Scotland,
the 2006  legislation  that  banned  smoking  in  public  places
reduced hospitalizations  for  asthma  by  18.2%.45
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Other  pollutants  appear  to  contribute  to  asthma  exa-
erbations, such  as  those  resulting  from  the  combustion  of
atural gas  and  engine  oil,  such  as  nitrogen  dioxide  (NO2).
hildren spend  most  of  their  time  outside  and  breathe  in  a
reater amount  of  pollutants  per  kilogram  of  weight  when
ompared to  adults,  and  the  increased  levels  of  NO2 are
ssociated with  the  severity  of  virus-induced  exacerbations.
his emphasizes  a  potential  synergism  between  these  two
nﬂammatory stimuli.44
Moreover,  controlled  exposure  in  asthma  patients  demon-
trated that  NO2 increases  the  response  to  inhaled  allergens.
 cohort  of  114  asthmatic  children  aged  between  8  and  11
ears were  monitored  for  symptoms,  measurement  of  peak
xpiratory ﬂow,  measurement  of  exposure  to  NO2, and  pres-
nce of  virus  in  nasal  secretion  during  a period  of  13  months.
ne or  more  viruses  were  detected  in  78%  of  the  reported
pisodes of  respiratory  symptoms;  it  was  demonstrated  that
xposure to  high  concentrations  of  NO2 in  the  week  before
he onset  of  a  viral  respiratory  infection  was  related  to  the
xacerbation severity.46
A  longitudinal  study  conducted  in  the  United  States  mea-
ured exposure  to  cigarette  smoke  in  1,444  children  with
sthma and  NO2 in  a  subset  of  663  of  them,  over  a  period
f nine  months.  They  demonstrated  increased  symptoms  in
hose exposed  to  NO2, but  only  among  non-atopic  children,
ith a  relative  risk  of  1.8  (95%  CI:  1.1  to  2.8).  There  was
o association  between  symptoms  and  increased  cigarette
moke exposure.47 Two  cross-sectional  studies  compared
hildren exposed  to  different  levels  of  cigarette  smoke  and
howed that  those  exposed  to  high  levels  had  higher  symp-
om scores  (p  <  0.01),  nocturnal  symptoms  (OR  3.4;  95%
I: 1.3  to  8.8),  and  need  for  relief  (p  =  0.03)  and  control
p =  0.02)  medications.48
A  study  in  which  937  children  aged  between  5  and  11
ears were  randomized  to  intervention  with  environmental
ducation guidelines  aimed  at  reducing  exposure,  showed
 reduction  in  exposure  in  the  group  that  received  instruc-
ions for  a  period  of  14  months.  The  intervention  group  had
ewer days  with  symptoms  (p  <  0.01)  after  one  year  of  follow-
p, in  addition  to  a  decrease  in  the  levels  of  dust  mites
Dermatophagoides pteronyssinus  and  Dermatophagoides
arinae) and  cockroach  antigens  in  the  home  environment.49
Fungal  sensitization  is  prevalent  in  children  with  asthma,
lthough few  studies  have  addressed  this  issue,  compared  to
tudies related  to  dust  mites.  One  study  demonstrated  that
hildren with  a  positive  skin  test  for  fungi  had  more  days  of
ymptoms when  compared  to  those  with  negative  tests  (6.3
s. 5.7  for  two  weeks,  p  =  0.04).  During  the  study  period,
ungi were  grown  from  the  intra-  and  extra-domestic  envi-
onment; increased  exposure  to  fungi  was  associated  with
ncreased days  of  symptoms  and  unscheduled  physician  visits
or asthma.44
reventive  and  therapeutic  aspects
he  preponderance  of  virus  participation  among  the  infec-
ious agents  in  exacerbations  makes  the  indiscriminate
rescription of  antibiotics  in  this  situation  pointless  in  most
ases.  Previous  studies  suggest  that  chest  radiography  is
mproperly and  unnecessarily  used  in  children  and  adults
ith acute  asthma  treated  in  emergency  rooms.50 Due  to
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he  alterations  that  are  usually  found  in  patients  during  asth-
atic crises,  such  as  hyperinsufﬂation,  ﬂuid  extravasation,
nd atelectasis  associated  with  hypoxemia,51 the  misinter-
retation of  these  ﬁndings  as  a  sign  of  pneumonia  is  common
nd, consequently,  unnecessary  prescription  of  antibiotics.
A  multicenter  study  of  734  asthmatic  patients  treated  in
mergency rooms  evaluated  the  request  for  additional  tests,
n this  case,  chest  radiography  and  blood  tests.  Severely  ill
atients, those  under  1  year,  and  those  with  a  comorbidity
ere excluded.  A  total  of  302  (41.0%)  children  underwent
dditional tests,  such  as  chest  radiography  (27.0%)  and  blood
ests (14.0%).  After  excluding  febrile  or  hypoxic  patients,
2.0% were  still  subjected  to  at  least  one  of  the  exams.50
espite  the  lack  of  Brazilian  data,  the  routine  of  pediatric
mergency care  services  in  the  country  appears  to  adhere
o this  rule.
In order  to  prevent  the  dissemination  of  viral  agents,  due
o the  high  capacity  of  viral  spread  through  droplets  and
omites, hand  washing,  and  the  use  of  respiratory  masks  are
imple strategies  that  have  been  proven  to  be  effective.52
taying  away  from  situations  that  favor  clusters  of  people
uring periods  of  increased  viral  circulation  has  been  rec-
mmended, although  there  are  no  studies  that  proved  the
ffectiveness of  this  strategy.52,53 The  use  of  substances  such
s herbal  preparations  including  Echinacea  and  vitamin  C
as  been  evaluated,  but  double-blind,  placebo-controlled
tudies failed  to  demonstrate  their  beneﬁt.54
The  prevention  of  viral  infections  through  vaccines  has
een the  most  effective  way  to  control  diseases  caused  by
iruses. In  the  case  of  respiratory  viruses,  the  only  vaccine
vailable is  for  Flu,  although  there  are  ongoing  studies  for
he development  of  vaccines  for  other  respiratory  viruses,
specially HRV.  However,  their  great  antigenic  diversity  hin-
ers research  success;  recent  studies  have  tried  to  establish
 more  adequate  antigenic  target  in  the  viral  structure.54,55
peciﬁc  RSV  immunoglobulin  has  been  successfully  used  in
educing hospitalizations  for  viral  bronchiolitis,  and  new
erspectives for  the  treatment  of  exacerbations  triggered
y viral  infections  have  emerged  from  studies  directed  to
ynthetic agonists  of  TLR3  receptor,  IFN-  agonist,  and  IL33-
nd IL25-antagonists,  among  others.56,57
There  is  no  speciﬁc  treatment  for  most  respiratory
iruses. Some  antivirals  have  been  successfully  used,  as  in
he case  of  Flu  infection,  such  as  amantadine,  rimantadine,
seltamivir phosphate,  and  zanamivir;  the  latter  is  not  indi-
ated  for  patients  with  asthma.  Ribavirin  is  indicated  for  the
reatment of  severe  infections  caused  by  RSV.  Other  antivi-
al agents  are  being  studied  and  have  not  yet  been  approved
or clinical  use,  such  as  pleconaril,  vapendavir,  pirodavir,  and
upintrivir.54
Glucocorticoids  have  potent  anti-inﬂammatory  effects
nd have  been  successfully  used  in  maintenance  treatment
n patients  with  persistent  asthma,  controlling  inﬂammation
nd preventing  exacerbations.  Some  studies  have  assessed
ts effect  on  virus-induced  asthma.  The  suppression  of
he release  of  pro-inﬂammatory  mediators  induced  by  HRV
nfection in  vitro  in  bronchial  epithelial  cells,  such  as  CCL5,
CL10, CXCL8,  and  IL6,  as  well  as  the  reduction  of  fac-
ors associated  with  remodeling,  was  achieved  after  the
se of  budesonide.58 Other  in  vitro  studies  documented
he action  of  other  corticosteroids  alone  or  in  combination
ith bronchodilators  or  leukotriene  antagonists  in  reducing
m
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he  release  of  several  inﬂammatory  molecules,  with  poten-
ial modulation  of  the  deleterious  effects  of  viruses  on  the
sthmatic population.51,59 Despite  the  proven  beneﬁts  of
nhaled corticosteroids  in  the  control  of  asthma  triggered
y multiple  factors,  their  action  on  virus-induced  exacer-
ations is  unclear.  The  use  of  low-to-moderate  doses  of
nhaled corticosteroids  as  maintenance  therapy  cannot  pre-
ent intermittent  viral-induced  wheezing.60,61
However,  better  results  have  been  obtained  with  the
ntermittent use  of  inhaled  corticosteroids  at  high  doses.62
iscussion
he  use  of  viral  detection  techniques  with  high  sensitiv-
ty and  speciﬁcity  has  increased  the  identiﬁcation  of  some
espiratory viruses  in  children  with  asthma  exacerbation.
he direct  or  indirect  immunoﬂuorescence  reactions  still
ave great  practical  importance,  as  they  can  detect  a  panel
f seven  viruses  (FLUV-  A  and  B,  PIV-  1-3,  hAdV  and  hRSV),
eing an  affordable  and  fast  method,  with  good  sensitivity,
specially in  children.18 It  is  currently  used  by  the  Brazilian
inistry of  Health  for  the  screening  of  respiratory  viruses
n the  diagnosis  of  severe  acute  ﬂu-like  illness  and  Flu-like
llness in  sentinel  units.
The  techniques  for  nucleic  acid  ampliﬁcation  (RT-PCR)
re more  expensive,  but  more  sensitive;  thus,  they  are
sed in  research  and  by  the  Brazilian  Ministry  of  Health  for
he identiﬁcation  and  genotyping  of  Flu.38 Furthermore,  it
llows for  the  identiﬁcation  of  some  viruses  with  signiﬁcant
linical and  epidemiological  importance,  such  as  hRV  and
ocavirus, not  identiﬁed  by  immunoﬂuorescence.17,54
As  for  the  method  used  to  obtain  the  sample,  it  is  worth
entioning the  controversial  issue  of  nasopharyngeal  swab
n viral  research.  Although  its  use  has  been  consolidated
or bacterial  infections  (S.  pneumoniae  and  S.  aureus),  its
ole in  viral  infections  still  deserves  some  consideration.
he authors  agree  that,  from  the  practical  point  of  view,
t is  more  feasible,  eliminating  the  use  of  suction  systems,
robes, and  more  specialized  training,  when  compared  to
spirate or  lavage  samples.  However,  only  those  with  more
dvanced technology  (ﬂocked  swab),  which  provides  best
apture and  release  of  cells  and,  therefore,  of  the  virus,
re equivalent  to  the  aspirate  in  terms  of  sample  quality.
evertheless, this  swab  is  not  routinely  used  in  services  and
esearches in  Brazil.38
Regarding  the  association  between  viral  infection  and
sthma exacerbation,  a  wide  variation  was  observed  con-
erning the  methods  of  studies  that  assessed  viral  infection
n exacerbated  asthmatic  children  in  the  studies  included
n this  review.  For  instance,  sample  size  varied  from  58  to
,052 cases  and  the  age  ranged  from  0  to  17  years.  This
nding is  important,  given  the  difﬁculty  in  deﬁning  asthma
n children  younger  than  3  years,  which  should  be  consid-
red in  case  selection.2,21 Moreover,  it  is  known  that  there  is
 considerable  difference  between  the  age  groups  and  the
ost prevalent  viruses,  such  as  the  hRSV.60 Regarding  the
ethods of  respiratory  secretion  collection  in  the  included
tudies, there  was  no  uniform  means  of  collection;  the  aspi-
ate was  used  in  43.8%  of  studies,  the  swab  in  31.6%,  both  in
5%, and  the  ﬂocked  swab  was  not  used.  There  was  a  wide
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variation  regarding  the  detection  methods  and  in  relation  to
some outcomes.
In addition  to  the  differences  in  sample  collections,  all
these studies  were  cross-sectional,  which  does  not  allow
for the  establishment  of  a  cause-effect  association  between
viral infection  and  the  onset  of  exacerbation,  but  suggest
such an  association.  In  relation  to  other  factors  known  to
be associated  with  uncontrolled  asthma,  such  as  allergens
and irritants,  most  studies  did  not  include  these  variables
in the  evaluation.  When  the  inﬂammatory  process  typical
of asthma  is  associated  with  a  viral  respiratory  infection,
there is  a  tendency  to  greater  severity  and  duration,  as  well
as a  poorer  response  to  conventional  treatment  of  the  acute
episode.32,33 The  involved  mechanisms  still  need  to  be  fully
elucidated, evidencing  the  synergistic  effect  between  viral
infection and  allergic  airway  inﬂammation  in  the  pathogen-
esis of  exacerbations.30,43
Another  pertinent  issue  is  the  role  of  inhaled  cortico-
steroids in  attenuating  the  inﬂammation  triggered  by  the
virus, also  seldom  mentioned  in  these  studies.  Its  action
in the  control  and  reduction  of  morbidity  associated  with
asthma is  well  established,2 but  it  is  still  a  controversial
subject regarding  the  prevention  of  viral-induced  wheez-
ing. Its  effectiveness  in  the  inﬂammatory  process  triggered
by a  virus  has  been  demonstrated  in  in  vitro  studies,51,58,59
but  studies  evaluating  its  clinical  beneﬁt  have  yet  to  reach
conclusive results.61,62
Regardless  of  the  direction  of  virus-allergen  interaction,
the present  ﬁndings  strongly  suggest  that  an  adequate  strat-
egy to  prevent  virus-induced  exacerbations  should  focus  on
two courses,  namely  the  improvement  of  antiviral  response
and the  reduction  of  allergic  sensitization  or  inﬂammation.
The latter  can  be  achieved  with  appropriate  treatment  of
the asthma  patient  at  risk  with  medications  that  reduce  air-
way  inﬂammation.  Conversely,  the  preventive  measures  for
viral infection  acquisition  and  its  timely  diagnosis  allow  for
a proper  management  of  exacerbations,  and  reduction  of
the number  of  hospitalizations  and  unnecessary  additional
tests, especially  in  children  who  are  febrile  at  the  time  of
assessment.
The association  between  viral  infection  and  asthma  in
childhood still  has  several  points  that  need  clariﬁcation,
especially the  actual  role  of  viruses  in  triggering  exacerba-
tions and  that  of  inhaled  corticosteroids  in  its  attenuation.
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